Table 2 Clinical characteristics of 74 BC patients
From: Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer
Variables | Statistics (N = 74) |
|---|---|
Age at diagnosis, years | Â |
Median | 50(42.25, 54.00) |
≤ 50 | 40(54.05%) |
> 50 | 34(45.95%) |
Histological grade | Â |
II | 62(83.78%) |
II-III | 1(1.35%) |
III | 6(8.11%) |
X | 5(6.76%) |
BC Molecular Subtypes | Â |
HR + HER2- | 35(47.30%) |
HER2+ | 26(35.14%) |
TN | 13(17.57%) |
Lymph Node Metastasis | Â |
Positive | 32(43.24%) |
Negative | 42(56.76%) |
Tumor Size (cm) | Â |
≤ 2 | 35(47.30%) |
2–5 | 35(47.30%) |
< 5 | 4(5.41%) |